ALXO: ALX Oncology Holdings Inc
ALXO exchange rate has changed by 6.57% for today. During the day, the instrument was traded at a low of 1.37 and at a high of 1.48.
Follow ALX Oncology Holdings Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ALXO News
- Jefferies reiterates Buy rating on ALX Oncology stock, sees potential in cancer programs
- Jefferies initiates coverage on ALX Oncology stock with Buy rating
- ALX Oncology Holdings Inc. (ALXO) Q3 2025 Earnings Call Transcript
- Duke Energy, KKR, Constellation Energy to report Friday, many more
- Alx Oncology stock jumps after presenting preclinical ADC data at conference
- ALX Oncology presents preclinical data for novel EGFR cancer drug
- Is Alnylam Pharmaceuticals (ALNY) Outperforming Other Medical Stocks This Year?
- ALX Oncology to present CD47 biomarker data for evorpacept at SITC
- ALX Oncology appoints board member Klencke as interim CMO
- ALX Oncology doses first patient in phase 1 trial of EGFR cancer drug
- Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Color Star Tech (NASDAQ:ADD), Adecoagro (NYSE:AGRO)
- ALX Oncology Holdings Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:ALXO)
- ALX Oncology Holdings Inc. (ALXO) Q2 2025 Earnings Call Transcript
- ALX Oncology Q2 2025 slides: biomarker strategy shows promise as cash runway extends
- Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor (NASDAQ:JAZZ)
- ALX Oncology reports annual meeting results
- ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference
- H.C. Wainwright maintains ALX Oncology stock Buy rating
- This Zscaler Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - CubeSmart (NYSE:CUBE), ALX Oncology Holdings (NASDAQ:ALXO)
Frequently Asked Questions
What is ALXO stock price today?
ALX Oncology Holdings Inc stock is priced at 1.46 today. It trades within 1.37 - 1.48, yesterday's close was 1.37, and trading volume reached 151. The live price chart of ALXO shows these updates.
Does ALX Oncology Holdings Inc stock pay dividends?
ALX Oncology Holdings Inc is currently valued at 1.46. Dividend policy depends on the company, while investors also watch -13.61% and USD. View the chart live to track ALXO movements.
How to buy ALXO stock?
You can buy ALX Oncology Holdings Inc shares at the current price of 1.46. Orders are usually placed near 1.46 or 1.76, while 151 and 6.57% show market activity. Follow ALXO updates on the live chart today.
How to invest into ALXO stock?
Investing in ALX Oncology Holdings Inc involves considering the yearly range 0.41 - 2.26 and current price 1.46. Many compare 9.77% and 247.62% before placing orders at 1.46 or 1.76. Explore the ALXO price chart live with daily changes.
What are ALX Oncology Holdings Inc stock highest prices?
The highest price of ALX Oncology Holdings Inc in the past year was 2.26. Within 0.41 - 2.26, the stock fluctuated notably, and comparing with 1.37 helps spot resistance levels. Track ALX Oncology Holdings Inc performance using the live chart.
What are ALX Oncology Holdings Inc stock lowest prices?
The lowest price of ALX Oncology Holdings Inc (ALXO) over the year was 0.41. Comparing it with the current 1.46 and 0.41 - 2.26 shows potential long-term entry points. Watch ALXO moves on the chart live for more details.
When did ALXO stock split?
ALX Oncology Holdings Inc has gone through stock splits historically. These changes are visible in , 1.37, and -13.61% after corporate actions.
- Previous Close
- 1.37
- Open
- 1.37
- Bid
- 1.46
- Ask
- 1.76
- Low
- 1.37
- High
- 1.48
- Volume
- 151
- Daily Change
- 6.57%
- Month Change
- 9.77%
- 6 Months Change
- 247.62%
- Year Change
- -13.61%
- Act
- 53.3
- Fcst
- 50.5
- Prev
- 51.0
- Act
- 55.0
- Fcst
- 52.9
- Prev
- 51.0
- Act
- 4.1%
- Fcst
- 3.9%
- Prev
- 4.5%
- Act
- 3.2%
- Fcst
- 3.5%
- Prev
- 3.4%
- Act
- Fcst
- Prev
- 407
- Act
- Fcst
- Prev
- 544
- Act
- Fcst
- $11.43 B
- Prev
- $13.09 B
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev